These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30867076)

  • 41. Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Curto M; Lionetto L; Fazio F; Corigliano V; Comparelli A; Ferracuti S; Simmaco M; Nicoletti F; Baldessarini RJ
    Schizophr Res; 2019 Jun; 208():465-466. PubMed ID: 30837204
    [No Abstract]   [Full Text] [Related]  

  • 42. Brain bioenergetics and redox state measured by
    Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D
    Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
    Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
    J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia.
    Fujigaki H; Mouri A; Yamamoto Y; Nabeshima T; Saito K
    Neurochem Int; 2019 May; 125():1-6. PubMed ID: 30731185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
    Bartoli F; Cioni RM; Callovini T; Cavaleri D; Crocamo C; Carrà G
    Schizophr Res; 2021 Jun; 232():61-62. PubMed ID: 34015557
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
    Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
    Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of tryptophan metabolism and food craving in the relationship between obesity and bipolar disorder.
    Dalkner N; Platzer M; Bengesser SA; Birner A; Fellendorf FT; Queissner R; Painold A; Mangge H; Fuchs D; Reininghaus B; Kapfhammer HP; Holasek SJ; Reininghaus EZ
    Clin Nutr; 2018 Oct; 37(5):1744-1751. PubMed ID: 28712531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of Proteomic Measures Across Serious Psychiatric Illness.
    Schulz SC; Overgaard S; Bond DJ; Kaldate R
    Clin Schizophr Relat Psychoses; 2017; 11(2):103-112. PubMed ID: 28742394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood-brain movements of tryptophan and tyrosine in manic-depressive illness and schizophrenia.
    Gaillard JM; Tissot R
    J Neural Transm Suppl; 1979; (15):189-96. PubMed ID: 290757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A plasma metabolomics study suggests alteration of multiple metabolic pathways in patients with bipolar disorder.
    Wei J; Zhao L; Du Y; Tian Y; Ni P; Ni R; Wang Y; Ma X; Hu X; Li T
    Psychiatry Res; 2021 May; 299():113880. PubMed ID: 33770709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The activation of the kynurenine pathway in a rat model with renovascular hypertension.
    Bartosiewicz J; Kaminski T; Pawlak K; Karbowska M; Tankiewicz-Kwedlo A; Pawlak D
    Exp Biol Med (Maywood); 2017 Apr; 242(7):750-761. PubMed ID: 28165296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A study of IL-1Β and IDO gene polymorphisms in patients with schizophrenia].
    Golimbet VE; Korovaĭtseva GI; Gabaeva MV; Velikaia NV; Snegireva AA; Kasparov SV; Kolesina NIu; Ganisheva TK; Savel'eva TM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):46-9. PubMed ID: 24988959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?
    Steen NE; Methlie P; Lorentzen S; Hope S; Barrett EA; Larsson S; Mork E; Almås B; Løvås K; Agartz I; Melle I; Berg JP; Andreassen OA
    J Clin Psychiatry; 2011 Nov; 72(11):1515-21. PubMed ID: 21367348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.
    Hebbrecht K; Skorobogatov K; Giltay EJ; Coppens V; De Picker L; Morrens M
    Front Immunol; 2021; 12():667179. PubMed ID: 34093561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Untargeted metabolomics of colonic digests reveals kynurenine pathway metabolites, dityrosine and 3-dehydroxycarnitine as red versus white meat discriminating metabolites.
    Rombouts C; Hemeryck LY; Van Hecke T; De Smet S; De Vos WH; Vanhaecke L
    Sci Rep; 2017 Feb; 7():42514. PubMed ID: 28195169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.
    De Picker L; Fransen E; Coppens V; Timmers M; de Boer P; Oberacher H; Fuchs D; Verkerk R; Sabbe B; Morrens M
    Front Immunol; 2019; 10():2971. PubMed ID: 32010121
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
    Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
    Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.